Company Profiles

driven by the PitchBook Platform

Galenea

Description

Developer of therapies for central nervous system diseases. The company engages in research and development of therapeutic drugs for diseases related to nervous systems.

2003

Founded

PRIVATE

Status

51-200

Employees

Grant

Latest Deal Type

$3M

Latest Deal Amount

$6M

Total Amount Raised

Description

Developer of therapies for central nervous system diseases. The company engages in research and development of therapeutic drugs for diseases related to nervous systems.

Website:

www.galenea.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Primary Office

50C Audubon Road Wakefield, MA 01880United States +1 (617) 374-1010
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Galenea's full profile, request a free trial.

Galenea Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Galenea Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Galenea Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
National Institutes of HealthGovernmentMinority000 0000000 0000
Otsuka PharmaceuticalsCorporationMinority000 0000000 0000
The Stanley Medical Research InstituteOtherMinority000 0000000 0000
National Institutes of Health Government
Otsuka Pharmaceuticals Corporation
The Stanley Medical Research Institute Other

Galenea Executive Team (3)

NameTitleBoard
Seat
Contact
Info
Mark BenjaminChief Executive Officer, Board Member & President
David Gerber Ph.DVice President, CNS Research
David NeafusChief Financial Officer
Mark Benjamin Chief Executive Officer, Board Member & President
David Gerber Ph.D Vice President, CNS Research
David Neafus Chief Financial Officer

Galenea Board Members (5)

NameRepresentingRoleSinceContact
Info
Masuhiro YoshitakeOtsuka PharmaceuticalsBoard Member000 0000
Stephen Gillies Ph.DSelfBoard Member000 0000
Stephen Heinemann Ph.DSelfBoard Member000 0000
Susumu Tonegawa Ph.DSelfScientific Advisory Board Member000 0000
Yasuo IrieSelfBoard Member000 0000
Masuhiro Yoshitake Board Member Otsuka Pharmaceuticals
Stephen Gillies Ph.D Board Member Self
Stephen Heinemann Ph.D Board Member Self
Susumu Tonegawa Ph.D Scientific Advisory Board Member Self
Yasuo Irie Board Member Self
Request full access to PitchBook